BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Tesaro, Inc. 

135 Clarendon Street #14R

Boston  Massachusetts  02116  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS










 Company News
Weak Phase 3 Nausea Drug Data Knocks Back Tesaro, Inc.'s Shares; Stock Down -24.75% At Market Close (Dec. 23, 2013) 12/23/2013 6:52:31 AM    More...
Tesaro, Inc. Announces Presentation of Rolapitant Pharmacokinetic (PK) Data at the MASCC/ISOO International Symposium 6/28/2013 9:00:12 AM    More...
Tesaro, Inc. and the European Network of Gynecological Oncological Trial Groups (ENGOT) Forge Partnership to Develop Niraparib for Ovarian Cancer 6/3/2013 9:41:24 AM    More...
Tesaro, Inc., Breast International Group (BIG), and the European Organization for Research and Treatment of Cancer Announce Collaboration for Niraparib Clinical Development in Breast Cancer 6/3/2013 9:38:38 AM    More...
Tesaro, Inc. Nets $91 Million 3/7/2013 8:46:30 AM    More...
Tesaro, Inc. Announces Third Quarter 2012 Operating Results 10/26/2012 6:42:21 AM    More...
Tesaro, Inc. to Announce Third Quarter 2012 Financial Results on Thursday, October 25th, 2012 10/17/2012 9:39:36 AM    More...
Tesaro, Inc. Announces Clearance of Investigational New Drug Application for TSR-011 10/3/2012 9:53:52 AM    More...
Tesaro, Inc. to Present at the 2012 Morgan Stanley Global Healthcare Conference 9/5/2012 9:45:12 AM    More...
Tesaro, Inc. Appoints Robert E. Martell, M.D., Ph.D. as Chief Medical Officer 9/5/2012 9:41:35 AM    More...
12